BPC-157, TB-500 20mg (Blend)

Peptide Science research editorial team.

BPC-157 plus TB-500 20mg Blend Profile

BPC-157 plus TB-500 20mg Blend from Peptide Science is the high-strength dual-active lyophilised vial pairing the synthetic 15-amino-acid pentadecapeptide BPC-157 with the 7-amino-acid active fragment of Thymosin Beta-4 (positions 17 to 23). The 20 mg combined load is the format chosen for longer in-vitro protocols where a single reconstitution event covers a multi-week experimental window.

Combined Pathway Background

BPC-157 is characterised in preclinical work for VEGFR2-receptor and FAK-paxillin pathway activity. TB-500 sequesters monomeric G-actin and is studied for its effects on cell-migration signalling via a separate receptor-independent route. Combined administration is a standard preclinical model for additive readouts on tissue-repair markers. Browse the parent healing peptide catalogue.

Vial Details

For the 10 mg combined-strength format, see BPC-157 plus TB-500 10mg Blend.

Handling and Shipping

The dual-active vial reconstitutes with bacteriostatic water for cell-culture and animal-model work. Each batch is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging. A Certificate of Analysis listing each active accompanies every order. For four-compound research adding KPV and GHK-Cu, see the 80mg Klow Blend.

For laboratory research and development use only. Not for human or veterinary consumption. Has not been evaluated by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws. Lyophilised vials store at 2 to 8 degrees Celsius; protect from light.